Seeking Alpha

Brett Scott » Articles » PFE |

More on PFE by Brett Scott
Articles by Ticker

Latest Comments on Brett Scott's Articles

  1. Critic on Will the Clouds Clear for Amgen?: Other than Amgen means many things to many people this doesnt say much more »
  2. Tibcomonkey on Correction and Clarification to Tysabri Post: Brett, Thanks for correcting the Remicade error. I'm curious... more »
  3. Let us be honest on Elan, Biogen Idec Won't Gain Much from Tysabri Approval: It is sad and pathetic and infuriating that the people who affect... more »
  4. JohnnyRoger on Elan, Biogen Idec Won't Gain Much from Tysabri Approval: Brett, I am going to try to be charitable considering your... more »
  5. SeekingAlpha Reader on Elan, Biogen Idec Won't Gain Much from Tysabri Approval: Let's see, on 1/7 Biogen announced that there were 20,400... more »
  6. User 142431 on Elan, Biogen Idec Won't Gain Much from Tysabri Approval: Perhaps with more experience you will learn to look a little... more »
  7. Tibcomonkey on Elan, Biogen Idec Won't Gain Much from Tysabri Approval: Brett, I'm sure J&J will be very concerned to learn they have... more »
  8. Grayray on Elan, Biogen Idec Won't Gain Much from Tysabri Approval: Brett, Dr_Dave has done an excellent job in explaing the... more »
  9. Dr_Dave on Elan, Biogen Idec Won't Gain Much from Tysabri Approval: Brett, You importantly failed to mention both cases of PML... more »
  10. Beta Delta on Investors May Prefer to Stay Away from DNA: help is on the way for DNA.. ... the cavalry is rounding up its... more »
  11. HarMegiddo on Forecast for ViroPharma's Pipeline: Mostly Shiny: well, that's where all the MRSA seem to be popping up, in high... more »
  12. Shlomo Greenberg_ on Forecast for ViroPharma's Pipeline: Mostly Shiny: This article reads like a bad high school book report. more »
  13. Zack Miller on Forecast for ViroPharma's Pipeline: Mostly Shiny: i miss shlomo greenberg. where did he go? more »
  14. twinnkie on Amgen's Bone Density Drug Needs to Prove Itself: amgn will hit 90 by early 2009 more »
  15. Amar Narayanan on Gilead Continues To Shine, But Watch The Competition: Your article has several factual errors. Just a couple of... more »